Evidence map›Paper›PMID 20677810›Full record

ArticleBiochemistry2010

Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.

Svetlana Kotova, Camasamudram Vijayasarathy, Emilios K Dimitriadis, Laertis Ikonomou, Howard Jaffe, Paul A Sieving

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. X-Linked Retinoschisis.Cold Spring Harbor perspectives in medicine · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Biology of retinoschisin.Advances in experimental medicine and biology · 2012
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Svetlana KotovaLBPS, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, USA.
Camasamudram Vijayasarathy
Emilios K Dimitriadis
Laertis Ikonomou
Howard Jaffe
Paul A Sieving
National Institute of Biomedical Imaging and Bioengineering · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institute of Neurological Disorders and Stroke · USNational Institute on Deafness and Other Communication Disorders · USNational Institutes of Health · US

Funding

Preclinical and Clinical Development of Treatment for X-linked RetinoschisisZIADC000065 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI SIEVING, PAUL · 2009 to 2019
$5.7M
Studies of Retinoschisin 1 on the membrane of retinal cell inner segmentsZICEB000052 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI DIMITRIADIS, EMILIOS K · 2010 to 2010
$20k
Studies of Retinoschisin 1 on the membrane of retinal cell inner segmentsZIAEB000052 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI DIMITRIADIS, EMILIOS K · 2009 to 2009
$15k
Intramural NIH HHS ZIA EB000052
6 · The paper itself

Abstract

Retinoschisin (RS1) is a retina-specific secreted protein encoding a conserved discoidin domain sequence. As an adhesion molecule, RS1 preserves the retinal cell architecture and promotes visual signal transduction. In young males, loss-of-function mutations in the X-linked retinoschisis gene (RS1) cause X-linked retinoschisis, a form of progressive blindness. Neither the structure of RS1 nor the nature of its anchoring and organization on the plasma membranes is fully understood. The discoidin C2 domains of coagulation factors V and VIII are known to interact with extracellular phosphatidylserine (PS). In this study we have used atomic force microscopy (AFM) to study the interactions of murine retinoschisin (Rs1) with supported anionic lipid bilayers in the presence of Ca(2+). The bilayers consisting of a single lipid, PS, and mixtures of lipids with or without PS were used. Consistent with previous X-ray diffraction studies, AFM imaging showed two distinct domains in pure PS bilayers when Ca(2+) was present. Upon Rs1 adsorption, these PS and PS-containing mixed bilayers underwent fast and extensive reorganization. Protein localization was ascertained by immunolabeling. AFM imaging showed the Rs1 antibody bound exclusively to the calcium-rich ordered phase of the bilayers pointing to the sequestration of Rs1 within those domains. This was further supported by the increased mechanical strength of these domains after Rs1 binding. Besides, changes in bilayer thickness suggested that Rs1 was partially embedded into the bilayer. These findings support a model whereby the Rs1 protein binds to PS in the retinal cell plasma membranes in a calcium-dependent manner.

Indexed as

AdsorptionAnimalsCalciumCell Adhesion MoleculesEye ProteinsFactor VIIILipid BilayersMiceMicroscopy, Atomic ForceModels, MolecularPhase TransitionPhosphatidylserinesProtein BindingProtein Structure, TertiaryRecombinant ProteinsCalciumCell Adhesion MoleculesEye ProteinsFactor VIIILipid BilayersPhosphatidylserinesRecombinant ProteinsRS1 protein, mouse

Identifiers

PMID20677810
PMCPMC2929131
OpenAlexW1967725755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.